NLRP3 and metabolic dysfunction-associated steatotic liver disease: “Matrix,” “macrophage polarization,” “nonalcoholic fatty liver disease,” “NLRP3 inflammasome,” and “target” represent the current research frontiers in macrophages and liver fibrosis and are now in the burst phase.